Just 7 Minutes Cancer Treatment New Injection Brings Major Breakthrough in Lung Cancer Care

Cancer treatment has long been associated with long hospital hours, emotional stress, and physical exhaustion for both patients and their families. From waiting for beds to spending hours under drips, the journey has often felt like a daily struggle. Now, a major shift in medical science is offering a new sense of relief.

In a significant development in cancer care, a new immunotherapy injection introduced by Swiss pharmaceutical company Roche has changed the treatment experience for lung cancer patients. This subcutaneous injection, recently launched in India, can complete the treatment process in just seven minutes, reducing hospital time by nearly 80 percent.

Earlier, patients undergoing lung cancer therapy had to spend hours connected to intravenous drips in hospitals. The new method allows patients to simply receive an injection and return home quickly, making the entire process far more convenient and less stressful. Doctors say this innovation is not just about speed but also about improving quality of life during treatment.

The drug is primarily used for non small cell lung cancer, one of the most common and aggressive forms of the disease in India. The treatment has been approved by the national drug authority, and each dose costs around 3.7 lakh rupees. It is administered once every 21 day cycle, and is also accessible for central government health scheme beneficiaries.

Medical experts believe lung cancer cases are rising rapidly in India, with nearly 80,000 new cases reported every year. Smoking and air pollution are major contributing factors, especially among men. Alarmingly, most patients are diagnosed at advanced stages, making timely and efficient treatment even more critical.

Doctors and hospital administrators are also welcoming the change. Experts from leading hospitals say the new injection significantly reduces pressure on hospital infrastructure. A treatment that earlier occupied a bed or chair for hours can now be completed in minutes, allowing more patients to be treated in the same time frame. This improves efficiency and reduces waiting times for others.

In clinical use, specialists report that the therapy has shown encouraging results with fewer side effects compared to traditional chemotherapy based approaches. Many hospitals have already started adopting it, and physicians note that it has reduced both physical discomfort and emotional strain for patients.

Already approved in over 85 countries and used by thousands of patients globally, this innovation is being seen as a turning point in cancer care. It is not only transforming treatment speed but also reshaping how hospitals manage critical care, marking a new chapter in modern oncology.